Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion. [electronic resource]
Producer: 20210604Description: 548-555 p. digitalISSN:- 1724-6016
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Female
- Humans
- Intravitreal Injections
- Macular Edema -- drug therapy
- Male
- Middle Aged
- Ranibizumab -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Retinal Vein Occlusion -- complications
- Retrospective Studies
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.